The San Francisco Giants' infield is facing a potential shake-up!
Casey Schmitt, the Giants' promising young infielder, has just undergone wrist surgery to remove a carpal boss, a procedure that will keep him off the field for 8 to 10 weeks. This news comes at a critical time for the Giants, who are already exploring options to strengthen their second base position. But here's where it gets interesting...
Schmitt's surgery might not significantly impact the team's plans, as he's expected to recover in time for Opening Day. However, it does highlight the team's need for improvement at second base. In 2025, the Giants' second basemen struggled mightily, posting a combined batting line of .217/.273/.343, a whopping 27% below league average. This glaring weakness has the Giants searching for solutions.
Last season, Schmitt, along with Tyler Fitzgerald, Christian Koss, and Brett Wisely, shared duties at second base. While Schmitt's overall performance was slightly below average, he has shown promise over the past two seasons, with a solid .241/.300/.420 batting line and 18 homers in 461 plate appearances. With no top prospects knocking on the door and the team's stated reluctance to commit long-term to starting pitchers, the Giants have a decision to make.
The team could pursue a top free agent like Bo Bichette, but alternatives such as Jorge Polanco and Ha-Seong Kim are also available. The trade market offers options like Brandon Lowe, Brendan Donovan, and CJ Abrams, as well as potential buy-low opportunities with Nolan Gorman and Luisangel Acuña. Schmitt's versatility and remaining minor league option provide the Giants with flexibility, but will they opt for a more permanent solution at second base?
For now, Schmitt remains the top internal candidate, but the Giants' next move will be telling. Will they bring in external talent, or is Schmitt's spot secure? And this is the part most fans are eager to find out. What do you think the Giants should do? Share your thoughts in the comments below!
